The Integrative Edge

GLP-1 medications like Ozempic, Wegovy, and Mounjaro have quickly become some of the most talked-about tools in health, weight loss, and metabolic care—but are we asking the right questions? In this episode of The Integrative Edge, we break down what GLP-1s actually do in the body, who they’re designed for, and where they fit into a bigger picture of long-term health. These medications were originally developed to support individuals with type 2 diabetes, but their impact on appetite regulation, blood sugar control, and weight loss has pushed them into the mainstream. With that rise in popularity comes confusion, mixed messaging, and often a lack of clarity around how they should (and shouldn’t) be used. We explore: How GLP-1 medications work from a physiological and hormonal standpoint Why appetite suppression alone isn’t the full story The difference between short-term weight loss and sustainable metabolic health Common pitfalls we’re seeing when these medications are used without proper support The importance of muscle mass, movement, and nutrition while using GLP-1s What happens when someone stops taking them Who may benefit most—and who should think twice From an integrative perspective, this conversation goes beyond “do they work?” and instead focuses on how to use them responsibly within a broader strategy that includes lifestyle, behavior change, and root-cause health. Because while GLP-1s can be powerful, they are not a replacement for the foundational habits that ultimately determine long-term outcomes. If you’ve been curious about these medications—or are currently using them—this episode will help you better understand how to approach them with intention, clarity, and a plan that supports your health beyond the scale.